Drug Shortage Report for SUBLINOX
Report ID | 86505 |
Drug Identification Number | 02391678 |
Brand name | SUBLINOX |
Common or Proper name | SUBLINOX |
Company Name | BAUSCH HEALTH, CANADA INC. |
Market Status | MARKETED |
Active Ingredient(s) | ZOLPIDEM TARTRATE |
Strength(s) | 5MG |
Dosage form(s) | TABLET (ORALLY DISINTEGRATING) |
Route of administration | SUBLINGUAL |
Packaging size | 30 |
ATC code | N05CF |
ATC description | HYPNOTICS AND SEDATIVES |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2019-06-14 |
Actual start date | |
Estimated end date | |
Actual end date | 2019-07-02 |
Shortage status | Resolved |
Updated date | 2019-07-05 |
Company comments | supplier delay |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2150 BOUL. ST-ELZEAR OUEST LAVAL, QUEBEC CANADA H7L 4A8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v11 | 2019-07-05 | French | Compare |
v10 | 2019-07-05 | English | Compare |
v9 | 2019-06-27 | French | Compare |
v8 | 2019-06-27 | English | Compare |
v7 | 2019-06-27 | French | Compare |
v6 | 2019-06-27 | English | Compare |
v5 | 2019-06-21 | French | Compare |
v4 | 2019-06-21 | English | Compare |
v3 | 2019-06-15 | English | Compare |
v2 | 2019-06-12 | French | Compare |
v1 | 2019-06-12 | English | Compare |
Showing 1 to 11 of 11